FDA Brief

Warning letters Drugs

FDA warning letter to

Glowface

High riskIssued Nov 3, 2025Posted Nov 5, 2025Center for Drug Evaluation and Research (CDER)

Glowface's website sells unapproved, misbranded injectable Botulax botulinum toxin drugs to U.S. consumers, FDA says.

What happened

FDA reviewed the website www.glowface.store and found that it offers unapproved and misbranded injectable botulinum toxin drug products for sale to U.S. consumers. The letter cites Botulax 200U set and Botulax 200U as examples, noting the website claim that the product is used for facial wrinkles, muscle spasm, hyperhidrosis, and blepharospasm. FDA says there are no approved applications for these products and their labeling lacks adequate directions for use.

What FDA found

  1. The website offers botulinum toxin drug products that are unapproved new drugs because no FDA-approved application is in effect for them.

    FD&C Act § 505(a) and § 301(d) [21 U.S.C. §§ 355(a), 331(d)]
  2. The products are prescription drugs, but their labeling does not bear adequate directions for use by a layperson.

    FD&C Act § 502(f)(1) [21 U.S.C. § 352(f)(1)]
  3. By offering the drugs for sale to U.S. consumers, the website causes misbranded drugs to be introduced into interstate commerce.

    FD&C Act § 301(a) [21 U.S.C. § 331(a)]

What FDA wants

FDA requests that www.glowface.store stop offering any unapproved and misbranded drugs for sale to U.S. consumers. The company must notify FDA in writing within 15 working days describing corrective steps and how it will prevent recurrence, or explain why it cannot complete corrections in that time.

Who should pay attention

  • online sellers of injectable cosmetic drugs
  • med spas and clinics that buy botulinum toxin products
  • consumers buying Botox-like products online

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk